Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion

[11] Hofma SH(2020)Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study) Eur Heart J 41 3715-651

[12] Iqbal J(2020)Paclitaxel-coated balloons: a safe alternative to drug-eluting stents for coronary in-stent restenosis Eur Heart J 41 3729-e226

[13] Serruys PW(2014)The efficacy of "hybrid" percutaneous coronary intervention in chronic total occlusions caused by in-stent restenosis: insights from a US multicenter registry Catheter Cardiovasc Interv 84 646-2653

[14] Silber S(2017)Percutaneous intervention in chronic total coronary occlusions caused by in-stent restenosis: procedural results and long-term clinical outcomes in the TORO (Spanish registry of chronic TOtal occlusion secondary to an occlusive in-stent RestenOsis) multicentre registry EuroIntervention 13 e219-221

[15] Abbas AE(2019)Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk Eur Heart J 40 2632-9

[16] Brewington SD(2011)Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO (Multicenter CTO Registry in Japan) score as a difficulty grading and time assessment tool JACC Cardiovasc Interv 4 213-592

[17] Dixon SR(2016)Development and validation of a novel scoring system for predicting technical success of chronic total occlusion percutaneous coronary interventions: the PROGRESS CTO (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention) Score JACC Cardiovasc Interv 9 1-2650

[18] Vemmou E(1985)Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects J Am Coll Cardiol 5 587-500

[19] Alaswad K(2018)Standardized end point definitions for coronary intervention trials: the Academic Research Consortium-2 Consensus Document Circulation 137 2635-e651

[20] Karmpaliotis D(2021)Definitions and clinical trial design principles for coronary artery chronic total occlusion therapies: CTO-ARC Consensus Recommendations Circulation 143 479-644

[11] Hofma SH(2020)Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study) Eur Heart J 41 3715-651

[12] Iqbal J(2020)Paclitaxel-coated balloons: a safe alternative to drug-eluting stents for coronary in-stent restenosis Eur Heart J 41 3729-e226

[13] Serruys PW(2014)The efficacy of "hybrid" percutaneous coronary intervention in chronic total occlusions caused by in-stent restenosis: insights from a US multicenter registry Catheter Cardiovasc Interv 84 646-2653

[14] Silber S(2017)Percutaneous intervention in chronic total coronary occlusions caused by in-stent restenosis: procedural results and long-term clinical outcomes in the TORO (Spanish registry of chronic TOtal occlusion secondary to an occlusive in-stent RestenOsis) multicentre registry EuroIntervention 13 e219-221

[15] Abbas AE(2019)Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk Eur Heart J 40 2632-9

[16] Brewington SD(2011)Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO (Multicenter CTO Registry in Japan) score as a difficulty grading and time assessment tool JACC Cardiovasc Interv 4 213-592

[17] Dixon SR(2016)Development and validation of a novel scoring system for predicting technical success of chronic total occlusion percutaneous coronary interventions: the PROGRESS CTO (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention) Score JACC Cardiovasc Interv 9 1-2650

[18] Vemmou E(1985)Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects J Am Coll Cardiol 5 587-500

[19] Alaswad K(2018)Standardized end point definitions for coronary intervention trials: the Academic Research Consortium-2 Consensus Document Circulation 137 2635-e651

[20] Karmpaliotis D(2021)Definitions and clinical trial design principles for coronary artery chronic total occlusion therapies: CTO-ARC Consensus Recommendations Circulation 143 479-644